跳至主要内容
临床试验/ISRCTN98243550
ISRCTN98243550已完成未知

Towards a patient supported, well tolerated and evidence based prophylactic swallowing exercise program to improve quality of life and swallowing function in head and neck cancer patients treated with chemoradiotherapy: a multicentre randomized controlled trial

Antwerp University Hopsital0 个研究点目标入组 150 人开始时间: 2018年12月21日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
150

研究概览

简要总结

2020 Protocol article in https://www.ncbi.nlm.nih.gov/pubmed/32122397 protocol (added 04/03/2020) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/36121560/ (added 20/09/2022) 2023 Results article in https://pubmed.ncbi.nlm.nih.gov/37550571/ Effect of service-delivery mode and overall adherence level (added 09/08/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Newly diagnosed squamous cell carcinoma of the oropharynx
  • 2. Stage III or IV cancer (according to TNM-7 classification)
  • 3. Treatment with radiotherapy or concomitant chemoradiotherapy with/without induction chemotherapy
  • 4. Demonstrating sufficient cognitive and language abilities

排除标准

  • 1. Recurrent carcinoma or metastasis from a non-HNC (head and neck cancer) carcinoma
  • 2. Previous radiotherapy and/or chemoradiotherapy ,or surgery in head-neck region with possible impact on swallowing function

研究者

发起方
Antwerp University Hopsital

相似试验